isoxazoles has been researched along with mefloquine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Franzblau, SG; Kozikowski, AP; Mao, J; Wan, B; Wang, Y | 1 |
| Franzblau, SG; Huang, Q; Kozikowski, AP; Mao, J; Pieroni, M; van Breemen, RB; Wan, B; Wang, Y; Yuan, H | 1 |
| Franzblau, SG; He, R; Mao, J; Pak, D; Wan, B; Wang, Y; Yuan, H | 1 |
3 other study(ies) available for isoxazoles and mefloquine
| Article | Year |
|---|---|
HTS, chemical hybridization, and drug design identify a chemically unique antituberculosis agent-coupling serendipity and rational approaches to drug discovery.
Topics: Animals; Antitubercular Agents; Cell Line; Chlorocebus aethiops; Drug Delivery Systems; Drug Design; Isoxazoles; Leucine; Mefloquine; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Small Molecule Libraries; Vero Cells | 2007 |
From serendipity to rational antituberculosis drug discovery of mefloquine-isoxazole carboxylic acid esters.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Drug Discovery; Esters; Female; Humans; Isoxazoles; Mefloquine; Mice; Microbial Sensitivity Tests; Microsomes, Liver; Mycobacterium tuberculosis; Vero Cells | 2009 |
Synthesis and antituberculosis activity of novel mefloquine-isoxazole carboxylic esters as prodrugs.
Topics: Antitubercular Agents; Carboxylic Acids; Esters; Humans; Isoxazoles; Mefloquine; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prodrugs | 2010 |